Aristeidis Chaidos

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos et al. · The Lancet Oncology · 2020 · 587 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762

Aristeidis Chaidos, Valentina S. Caputo, Katerina Gouvedenou et al. · Blood · 2013 · 202 citations

Pharmacy, Medicinal Chemistry, Pharmacology +6

Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21

Anindita Roy, Gillian Cowan, Adam J. Mead et al. · Proceedings of the National Academy of Sciences · 2012 · 166 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

Aristeidis Chaidos, Scott D. Patterson, Richard Szydlo et al. · Blood · 2012 · 162 citations · Full text

Life Sciences, Hematology, Immunology +11